Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease APJ De Vries, P Ruggenenti, XZ Ruan, M Praga, JM Cruzado, IM Bajema, ... The lancet Diabetes & endocrinology 2 (5), 417-426, 2014 | 427 | 2014 |
Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss F Moreso, M Ibernon, M Goma, M Carrera, X Fulladosa, M Hueso, ... American Journal of Transplantation 6 (4), 747-752, 2006 | 368 | 2006 |
Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats N Lloberas, JM Cruzado, M Franquesa, I Herrero-Fresneda, J Torras, ... Journal of the American Society of Nephrology 17 (5), 1395-1404, 2006 | 297 | 2006 |
Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes E Porrini, P Ruggenenti, CE Mogensen, DP Barlovic, M Praga, ... The lancet Diabetes & endocrinology 3 (5), 382-391, 2015 | 233 | 2015 |
Hepatitis C virus infection and de novo glomerular lesions in renal allografts JM Cruzado, M Carrera, J Torras, JM Grinyo American Journal of Transplantation 1 (2), 171-178, 2001 | 212 | 2001 |
Presence of FoxP3+ regulatory T cells predicts outcome of subclinical rejection of renal allografts O Bestard, JM Cruzado, J Torras, M Goma, D Sero, F Moreso, ... Journal of the American Society of Nephrology 19 (10), 2020-2026, 2008 | 186 | 2008 |
Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates O Bestard, JM Cruzado, M Mestre, A Caldés, J Bas, M Carrera, J Torras, ... The Journal of Immunology 179 (7), 4901-4909, 2007 | 186 | 2007 |
Promising effects of ischemic preconditioning in renal transplantation J Torras, I Herrero-Fresneda, N Lloberas, M Riera, JM Cruzado, ... Kidney international 61 (6), 2218-2227, 2002 | 184 | 2002 |
Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients M Bodro, N Sabé, F Tubau, L Lladó, C Baliellas, J Roca, JM Cruzado, ... Transplantation 96 (9), 843-849, 2013 | 179 | 2013 |
Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model M Franquesa, E Herrero, J Torras, E Ripoll, M Flaquer, M Goma, ... Stem cells and development 21 (17), 3125-3135, 2012 | 160 | 2012 |
A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism JM Cruzado, P Moreno, JV Torregrosa, O Taco, R Mast, ... Journal of the American Society of Nephrology 27 (8), 2487-2494, 2016 | 158 | 2016 |
Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients O Bestard, P Nickel, JM Cruzado, C Schoenemann, O Boenisch, A Sefrin, ... Journal of the American Society of Nephrology 19 (7), 1419-1429, 2008 | 151 | 2008 |
Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats JM Cruzado, N Lloberas, J Torras, M Riera, C Fillat, I Herrero-Fresneda, ... Diabetes 53 (4), 1119-1127, 2004 | 137 | 2004 |
Pretransplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation O Bestard, M Lucia, E Crespo, B Van Liempt, D Palacio, E Melilli, J Torras, ... American Journal of Transplantation 13 (7), 1793-1805, 2013 | 132 | 2013 |
Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease D Viasus, C Garcia-Vidal, JM Cruzado, J Adamuz, R Verdaguer, ... Nephrology Dialysis Transplantation 26 (9), 2899-2906, 2011 | 132 | 2011 |
Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance JM Cruzado, T Casanovas-Taltavull, J Torras, C Baliellas, S Gil-Vernet, ... American Journal of Transplantation 3 (3), 357-360, 2003 | 132 | 2003 |
Macrophage in chronic kidney disease R Guiteras, M Flaquer, JM Cruzado NDT Plus 9 (6), 765-771, 2016 | 130 | 2016 |
Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation M Lúcia, S Luque, E Crespo, E Melilli, JM Cruzado, J Martorell, M Jarque, ... Kidney international 88 (4), 874-887, 2015 | 127 | 2015 |
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study SP Berger, C Sommerer, O Witzke, H Tedesco, S Chadban, S Mulgaonkar, ... American Journal of Transplantation 19 (11), 3018-3034, 2019 | 120 | 2019 |
HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms I Herrero-Fresneda, J Torras, M Franquesa, A Vidal, JM Cruzado, ... Kidney International 70 (2), 265-274, 2006 | 114 | 2006 |